Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept in Psoriasis Vulgaris
NCT00287547Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Mar 1997
- Primary completion
- Jan 1998
- Countries
- 1
01
Overview
A Phase 2 trial of abatacept in Psoriasis vulgaris (PV), sponsored by Bristol Myers Squibb. Started Mar 1997; status: completed.
02
Drugs
abatacept
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT00287547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00287547.